Akari Therapeutics, Plc (AKTX)
NASDAQ·Healthcare·Biotechnology
$9.75
-2.99%
Mkt Cap $4.49K
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$24.75
Range $19.50 – $30.00
Implied Upside
+153.8%
Consensus $24.75 vs current $9.75
NASDAQ·Healthcare·Biotechnology
$9.75
-2.99%
Mkt Cap $4.49K
No recent rating data.
Price Target (3 analysts)
$24.75
Range $19.50 – $30.00
+153.8%
Consensus $24.75 vs current $9.75